ID
27833
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (2)
- 11/30/17 11/30/17 -
- 1/2/18 1/2/18 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
November 30, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Screening Lymphoma GOAL Trial B-cell Lymphoma NCT02499003
Screening Lymphoma Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Description
Lymphoma Characteristics
Description
Stage at first diagnosis
Data type
text
Description
Current stage
Data type
text
Description
Histology at first diagnosis
Data type
boolean
Description
Date of histology at first diagnosis
Data type
date
Description
CD20 positive disease first diagnosis
Data type
boolean
Description
Entity at first diagnosis
Data type
text
Description
Other entity at first diagnosis
Data type
text
Description
IPI score at first diagnosis
Data type
integer
Description
aaIPI score at first diagnosis
Data type
integer
Description
FLIPI score at first diagnosis
Data type
integer
Description
MIPI score at first diagnosis
Data type
float
Description
Histology at screening
Data type
boolean
Description
Date of histology at screening
Data type
date
Description
CD20 positive disease screening
Data type
boolean
Description
Entity at screening
Data type
text
Description
Date of transformation
Data type
date
Description
Secondary IPI score
Data type
integer
Description
Secondary aaIPI score
Data type
integer
Description
Current FLIPI score
Data type
integer
Description
FLIPI grade
Data type
text
Description
B Symptoms
Similar models
Screening Lymphoma Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM